National Chapter Vision Webinar: Emerging Therapies and Research for Inherited Retinal Diseases
Saturday, November 12th, 2022, 12:00 p.m. – 1:30 p.m. (EDT)
The 90-minute national webinar will feature guest presentations on emerging gene therapies from Opus, a potential anti-oxidative treatment from Nacuity, and a promising cell-based treatment from OkuloVision. The panel will answer questions from the audience on a wide range of research, clinical, and therapy development topics.
Get updates on Foundation Event
Location
Virtual, MD
Featured Speakers:
- Jami R. Kern, MBA PhD, Nacuity Pharmaceuticals, SVP, Chief Clinical Officer
- Marie Csete, MD, PhD, Chief Executive Officer, OkuloVision
- Erin O'Neil, MD, VP of Clinical Development , Opus Genetics
- Claire Gelfman, PhD, Chief Scientific Officer, Foundation Fighting Blindness
- Ben Shaberman, VP, Science Communications, Foundation Fighting Blindness
The Foundation Fighting Blindness thanks our partners for helping to bring hope and results to people affected by blinding retinal diseases.
Visionary Champion National Partners
Outreach Gold Partners
Outreach Silver Partners
AGTC
Lexitas
MeiraGTx
Novartis
Parexel
Spark Therapeutics
Outreach Bronze Partner
Apellis
InFocus Clinical Research
PIXIUM VISION
